874 related articles for article (PubMed ID: 31596048)
1. Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes.
Ghouse J; Isaksen JL; Skov MW; Lind B; Svendsen JH; Kanters JK; Olesen MS; Holst AG; Nielsen JB
Diabetes Obes Metab; 2020 Feb; 22(2):231-242. PubMed ID: 31596048
[TBL] [Abstract][Full Text] [Related]
2. Mean HbA
Forbes A; Murrells T; Mulnier H; Sinclair AJ
Lancet Diabetes Endocrinol; 2018 Jun; 6(6):476-486. PubMed ID: 29674135
[TBL] [Abstract][Full Text] [Related]
3. Glycaemic control and sepsis risk in adults with type 1 diabetes.
Balintescu A; Lind M; Andersson Franko M; Oldner A; Cronhjort M; Eliasson B; Svensen C; Mårtensson J
Diabetes Obes Metab; 2023 Jul; 25(7):1942-1949. PubMed ID: 36949627
[TBL] [Abstract][Full Text] [Related]
4. Risk of first stroke in people with type 2 diabetes and its relation to glycaemic control: A nationwide observational study.
Zabala A; Darsalia V; Holzmann MJ; Franzén S; Svensson AM; Eliasson B; Patrone C; Nyström T; Jonsson M
Diabetes Obes Metab; 2020 Feb; 22(2):182-190. PubMed ID: 31576643
[TBL] [Abstract][Full Text] [Related]
5. Glycaemic markers and all-cause mortality in older adults with and without diabetes: the Atherosclerosis Risk in Communities (ARIC) study.
Rooney MR; Tang O; Pankow JS; Selvin E
Diabetologia; 2021 Feb; 64(2):339-348. PubMed ID: 32990802
[TBL] [Abstract][Full Text] [Related]
6. Mortality in Individuals Aged 80 and Older with Type 2 Diabetes Mellitus in Relation to Glycosylated Hemoglobin, Blood Pressure, and Total Cholesterol.
Hamada S; Gulliford MC
J Am Geriatr Soc; 2016 Jul; 64(7):1425-31. PubMed ID: 27295278
[TBL] [Abstract][Full Text] [Related]
7. Glycaemic control and mortality in older people with type 2 diabetes: The Fremantle Diabetes Study Phase II.
Bruce DG; Davis WA; Davis TME
Diabetes Obes Metab; 2018 Dec; 20(12):2852-2859. PubMed ID: 30003670
[TBL] [Abstract][Full Text] [Related]
8. Early glycaemic changes after initiation of oral antidiabetic medication and risk of major adverse cardiovascular events: results from a large primary care population of patients with type 2 diabetes.
Ghouse J; Blanche P; Skov MW; Lind B; Vaag A; Kanters JK; Svendsen JH; Køber L; Olesen MS; Gerds TA; Holst AG; Nielsen JB
Eur Heart J Cardiovasc Pharmacother; 2021 Nov; 7(6):486-495. PubMed ID: 32614428
[TBL] [Abstract][Full Text] [Related]
9. The Legacy Effect in Type 2 Diabetes: Impact of Early Glycemic Control on Future Complications (The Diabetes & Aging Study).
Laiteerapong N; Ham SA; Gao Y; Moffet HH; Liu JY; Huang ES; Karter AJ
Diabetes Care; 2019 Mar; 42(3):416-426. PubMed ID: 30104301
[TBL] [Abstract][Full Text] [Related]
10. Metabolic memory and all-cause death in community-based patients with type 2 diabetes: the Fremantle Diabetes Study.
Davis TM; Chubb SA; Bruce DG; Davis WA
Diabetes Obes Metab; 2016 Jun; 18(6):598-606. PubMed ID: 26936654
[TBL] [Abstract][Full Text] [Related]
11. Peripheral arterial disease and type 2 diabetes: Older patients still exhibit a survival benefit from glucose control.
Höbaus C; Herz CT; Wrba T; Koppensteiner R; Schernthaner GH
Diab Vasc Dis Res; 2020; 17(2):1479164120914845. PubMed ID: 32308023
[TBL] [Abstract][Full Text] [Related]
12. Haemoglobin A1c and 5-year all-cause mortality in French type 2 diabetic patients aged 70 years and older: The GERODIAB observational cohort.
Doucet J; Verny C; Balkau B; Scheen AJ; Bauduceau B
Diabetes Metab; 2018 Dec; 44(6):465-472. PubMed ID: 29859993
[TBL] [Abstract][Full Text] [Related]
13. Visit-to-Visit Variability of Hemoglobin A
Ghouse J; Skov MW; Kanters JK; Lind B; Isaksen JL; Blanche P; Haunsø S; Køber L; Svendsen JH; Olesen MS; Holst AG; Gerds TA; Nielsen JB
Diabetes Care; 2019 Jan; 42(1):134-141. PubMed ID: 30352898
[TBL] [Abstract][Full Text] [Related]
14. Patient-level predictors of achieving early glycaemic control in Type 2 diabetes mellitus: a population-based study.
Svensson E; Baggesen LM; Thomsen RW; Lyngaa T; Pedersen L; Nørrelund H; Buhl ES; Haase CL; Johnsen SP
Diabet Med; 2016 Nov; 33(11):1516-1523. PubMed ID: 27412570
[TBL] [Abstract][Full Text] [Related]
15. Poor glycaemic control is associated with increased risk of neurodevelopmental disorders in childhood-onset type 1 diabetes: a population-based cohort study.
Liu S; Kuja-Halkola R; Larsson H; Lichtenstein P; Ludvigsson JF; Svensson AM; Gudbjörnsdottir S; Tideman M; Serlachius E; Butwicka A
Diabetologia; 2021 Apr; 64(4):767-777. PubMed ID: 33454829
[TBL] [Abstract][Full Text] [Related]
16. Effects of canagliflozin compared with placebo on major adverse cardiovascular and kidney events in patient groups with different baseline levels of HbA
Young TK; Li JW; Kang A; Heerspink HJL; Hockham C; Arnott C; Neuen BL; Zoungas S; Mahaffey KW; Perkovic V; de Zeeuw D; Fulcher G; Neal B; Jardine M
Diabetologia; 2021 Nov; 64(11):2402-2414. PubMed ID: 34448033
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of Long-term HbA
Sheng CS; Tian J; Miao Y; Cheng Y; Yang Y; Reaven PD; Bloomgarden ZT; Ning G
Diabetes Care; 2020 Jun; 43(6):1185-1190. PubMed ID: 32229597
[TBL] [Abstract][Full Text] [Related]
18. Effects of the Norfolk diabetes prevention lifestyle intervention (NDPS) on glycaemic control in screen-detected type 2 diabetes: a randomised controlled trial.
Sampson M; Clark A; Bachmann M; Garner N; Irvine L; Howe A; Greaves C; Auckland S; Smith J; Turner J; Rea D; Rayman G; Dhatariya K; John WG; Barton G; Usher R; Ferns C; Pascale M;
BMC Med; 2021 Aug; 19(1):183. PubMed ID: 34407811
[TBL] [Abstract][Full Text] [Related]
19. International comparison of glycaemic control in people with type 1 diabetes: an update and extension.
Prigge R; McKnight JA; Wild SH; Haynes A; Jones TW; Davis EA; Rami-Merhar B; Fritsch M; Prchla C; Lavens A; Doggen K; Chao S; Aronson R; Brown R; Ibfelt EH; Svensson J; Young R; Warner JT; Robinson H; Laatikainen T; Rautiainen P; Delemer B; Souchon PF; Diallo AM; Holl RW; Schmid SM; Raile K; Tigas S; Bargiota A; Zografou I; Luk AOY; Chan JCN; Dinneen SF; Buckley CM; Kgosidialwa O; Cherubini V; Gesuita R; Strele I; Pildava S; Veeze H; Aanstoot HJ; Mul D; Jefferies C; Cooper JG; Løvaas KF; Battelino T; Dovc K; Bratina N; Eeg-Olofsson K; Svensson AM; Gudbjornsdottir S; Globa E; Zelinska N
Diabet Med; 2022 May; 39(5):e14766. PubMed ID: 34890078
[TBL] [Abstract][Full Text] [Related]
20. Distinct trajectories of HbA
Rathmann W; Schwandt A; Hermann JM; Kuss O; Roden M; Laubner K; Best F; Ebner S; Plaumann M; Holl RW;
Diabet Med; 2019 Nov; 36(11):1468-1477. PubMed ID: 31392761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
